Scott Van Etten serves as the Area Business Director for Oncology Biosimilars at Celltrion Healthcare Co., Ltd., where he leverages his extensive experience in oncology and immunology to drive market penetration and growth in the highly competitive biosimilars landscape. Based in Charlotte, NC, Scott oversees...
Scott Van Etten serves as the Area Business Director for Oncology Biosimilars at Celltrion Healthcare Co., Ltd., where he leverages his extensive experience in oncology and immunology to drive market penetration and growth in the highly competitive biosimilars landscape. Based in Charlotte, NC, Scott oversees operations across the Central and Eastern United States, focusing on building strategic relationships with key stakeholders, including healthcare providers (HCPs), C-suite executives, and directors of pharmacy (DOPs). His expertise in account-based selling and contracting for "Buy and Bill" injectables positions him as a pivotal figure in the successful integration of biosimilars into clinical settings.
In his current role, Scott is spearheading several key projects aimed at enhancing the adoption of oncology biosimilars, ensuring that healthcare professionals are equipped with the knowledge and resources necessary to optimize patient care. His commitment to people development and team productivity is evident as he inspires his account management teams to excel in both clinical selling and biologic infusions. Scott's launch experience is particularly valuable as he navigates the complexities of introducing innovative therapies to the market, ensuring compliance with Medicare Part D regulations and maximizing market share.
Scott's cross-functional team leadership skills enable him to collaborate effectively with various departments, fostering an environment of innovation and strategic alignment. His deep understanding of market dynamics, coupled with his passion for improving patient outcomes, positions him as a thought leader in the oncology biosimilars space, driving Celltrion Healthcare's mission to provide accessible and effective treatment options for patients.
